How do you decide if a CRO advisory before a full-time hire is right for a Series A company when missed two quarters of quota in 2027?

What a CRO Advisory Is and Why It Matters Here

A fractional or advisory CRO is a senior revenue operator who works part-time or on a defined engagement, typically 15-25 hours a week, rather than joining as a full-time executive. The model exists because most revenue problems at the Series A stage are not "we lack a vision for go-to-market" - they are "we have a specific mechanical breakdown in how deals move from lead to close." A company that has missed two quarters of quota is usually not confused about its market. It has a leak: reps chasing unqualified leads, a forecast built on hope instead of evidence, or a pricing motion that stalls at the proposal stage. An advisory engagement is built to find and close that leak fast, without the six-figure fixed cost and 60-90 day ramp of a full-time hire.

This matters because Series A companies operate under real constraints that change the calculus entirely compared to a Series C or public company. Runway is finite, headcount is lean, and every dollar spent on leadership has to show up in pipeline within a quarter or two, not a fiscal year. When a board asks "why did we miss quota again," the honest answer at this stage is almost always operational, not existential - reps aren't being coached, the CRM has no discipline, or the ideal customer profile drifted without anyone noticing. A RevOps-minded advisor treats the sales motion like a system with measurable inputs and outputs, which is exactly the lens a struggling Series A company needs before it commits to a permanent leadership hire it may not be ready to define or manage well.

The decision to bring in an advisor instead of a full-time CRO also protects optionality. Hiring a full-time CRO is a bet on a specific person's judgment about market strategy, org design, and long-term scaling - decisions that are hard to reverse once comp, equity, and reporting lines are set. An advisory engagement is reversible by design: it runs for a fixed period, it has a defined scope, and it produces an artifact - a clean pipeline, a documented process, a clear read on whether the miss was execution or product - that the company can act on regardless of who ends up in the seat long-term.

The Step-by-Step Process

Deciding between advisory and full-time hire follows a repeatable sequence rather than a gut call. The first step is always diagnosis: before anyone signs a contract, someone needs to determine whether the two missed quarters trace back to a sales-execution problem or a product-market-fit problem, because an advisor cannot fix the latter. This typically takes one to two weeks of pipeline and call-recording review.

If the diagnosis points to execution - qualification discipline, forecast accuracy, rep coaching, pricing structure - the company moves into a short advisory engagement, usually 8-12 weeks, with weekly deliverables and a clear exit criteria defined up front. If the diagnosis instead surfaces a retention or fit problem (high churn, low usage, a value proposition that doesn't hold up under real customer scrutiny), the right move is to pause sales hiring entirely and route the effort to product and customer discovery instead - no CRO, fractional or full-time, fixes that.

By the end of the engagement, the company has hard evidence - pipeline coverage ratio, cycle-time change, rep attainment trend - to decide the next step rather than guessing. That evidence-based checkpoint is the entire point of running advisory before a full-time search: it turns "should we hire a CRO" from a values debate into a data-backed decision the board and CEO can align on.

Costs, Timelines, and Typical Ranges

A fractional CRO advisory engagement for a company at this stage typically runs $15,000-25,000 per month for 40-60 hours of hands-on work, or $8,000-12,000 per month for a lighter two-day-a-week retainer focused on coaching and pipeline review rather than full operational ownership. Compare that to a full-time CRO, who commands $250,000-350,000 in total cash compensation plus a meaningful equity grant, and who typically needs 60-90 days before contributing meaningfully to pipeline - time a company that has already missed two quarters often cannot spare.

The advisory engagement itself usually breaks into three phases over roughly 90 days. The first 30 days are diagnostic: auditing every open opportunity above a meaningful deal-size threshold, categorizing them as real, stalled, or dead, and reviewing a sample of call recordings and lost-deal notes to find the pattern behind the miss. This phase alone often costs $15,000-25,000 and is the highest-leverage spend in the entire engagement because it tells the company, with evidence rather than opinion, what actually broke.

The second 30-day block is intervention: implementing a qualification framework with mandatory CRM fields, standing up a weekly pipeline review built around next-steps rather than forecast optimism, and building a simple pricing playbook with two or three packaged options and clear discount guardrails. This phase costs roughly the same as the first and is where most of the measurable improvement in pipeline health shows up.

The final 30 days are about the decision itself - whether the company converts the advisor into a search for a full-time CRO, extends the advisory relationship at a lighter cadence, or concludes the CEO can run sales long-term with quarterly check-ins. If the company chooses to hire full-time at this point, the advisor typically writes the job description, screens the first round of candidates, and hands off for a small additional fee rather than a full monthly retainer, since the heaviest lift is already done.

Where Teams Get It Wrong

The most common mistake is skipping diagnosis and jumping straight to a full-time search because a missed quota "feels" like it needs a permanent leader. Boards especially tend to push for headcount as a signal of seriousness, but hiring a full-time CRO before anyone has confirmed the root cause of the miss often means paying six figures to discover, three months later, that the real issue was a pricing page or an undocumented qualification process an advisor could have fixed for a fraction of the cost.

The second mistake is treating the advisory engagement as strategic consulting rather than operational execution. An advisor who spends the engagement building slide decks and go-to-market frameworks instead of sitting on live deal calls and rebuilding the CRM is not going to move the pipeline metrics that matter. The right advisory engagement is hands-on: reviewing real opportunities, coaching real reps on real calls, and shipping concrete process changes within the first two weeks, not the last two.

The third mistake is letting the CEO opt out of the process instead of staying the primary closer during the engagement. At the Series A stage the CEO is frequently still the best salesperson in the company, and an advisor's job is to build structure around that reality, not replace it prematurely. When the CEO disengages from deal reviews and CRM discipline, the gains from the advisory period tend to evaporate the moment the engagement ends.

A fourth, quieter mistake is ignoring the retention signal. If net revenue retention is weak or churn is high, no amount of front-end sales coaching will produce a durable fix, and a company that spends an advisory budget - or worse, a full-time CRO's salary - chasing a pipeline problem that is actually a product problem will still be missing quota two quarters later, just with less cash to show for it.

Decision Framework: When to Choose What

The clearest way to decide is to separate the question into three signals, each of which points toward advisory, full-time, or neither.

If the CEO wants to remain the primary closer and simply needs operational scaffolding - CRM discipline, a qualification framework, coaching - the advisory model can run indefinitely at a lighter cadence, often a few days a month, because the underlying need is structure, not headcount. If the plan calls for scaling the sales team materially within the next two quarters, or the board is explicitly requiring a dedicated executive before a Series B raise, that points to converting the advisory relationship into a full-time search, ideally with the outgoing advisor helping write the role and screen candidates so institutional knowledge from the engagement doesn't walk out the door.

The framework is deliberately simple because the underlying decision should be too: match the structure to what the company actually needs to fix in the next 90 days, and revisit the question every quarter rather than treating it as permanent. Companies that build this into a recurring RevOps checkpoint - reassessing advisory versus full-time at each quarterly board meeting - tend to avoid both the overpaying mistake and the under-resourcing mistake that plague Series A revenue leadership decisions.

Related questions

How long should a fractional CRO advisory engagement last before converting to full-time?

Most effective engagements run 8-12 weeks, long enough to diagnose the root cause, implement process fixes, and generate evidence - pipeline coverage, cycle time, attainment - to inform the full-time decision without dragging into an open-ended arrangement.

Can a Series A company run sales without any CRO, fractional or full-time?

Yes, if the CEO is a capable closer and the team stays under 3-4 reps. Many companies operate this way until scaling pressure or board requirements force a dedicated revenue leader.

What's the difference between a fractional CRO and a sales consultant?

A fractional CRO operates inside the business - live on deal calls, in the CRM daily, accountable to pipeline outcomes. A consultant typically delivers recommendations and leaves execution to the internal team.

Should the fractional CRO help write the full-time CRO job description?

Yes, when the company decides to convert. The advisor has direct visibility into what the role actually needs to fix, which produces a far more accurate job description than one written from a generic template.

FAQ

What is the typical monthly cost of a fractional CRO advisory for a Series A company? Most engagements run $15,000-25,000 per month for 40-60 hours of hands-on work, or $8,000-12,000 for a lighter two-day-a-week retainer. Both are dramatically cheaper than a full-time CRO's $250,000-350,000 total compensation package.

How do you measure whether the advisory engagement actually worked? Track pipeline coverage ratio, average sales cycle length, and rep attainment before and after the engagement. A successful advisory period typically improves pipeline coverage from under 2x to 3x or better and shortens the sales cycle meaningfully within 60 days.

What if the fractional CRO can't fix the quota miss within the engagement?

If pipeline health hasn't improved after a full diagnostic and intervention cycle, the underlying issue is likely product-market fit rather than sales execution, and the company should redirect effort to customer discovery rather than extending the sales-focused engagement.

Does a fractional CRO replace the need for a VP of Sales? No. A fractional CRO typically operates above or alongside a VP of Sales or the CEO acting as head of sales, focused on strategy, process, and coaching rather than day-to-day rep management, though at very early stages they may do both.

Is it normal for the CEO to stay the primary closer during an advisory engagement? Yes, this is the most common Series A pattern. The advisor builds process and coaches from the sidelines while the CEO continues closing the largest deals, provided the CEO commits to following the new process rather than working around it.

When does it make sense to skip advisory entirely and hire full-time immediately? When the board has already committed to a Series B timeline requiring a dedicated revenue leader, or when the company needs to scale the sales team from a handful of reps to eight or more within two quarters - situations where the ramp-up cost of a full-time hire is worth paying immediately.

Sources

• https://hbr.org/topic/subject/sales
• https://www.saastr.com
• https://openviewpartners.com/blog
• https://www.gartner.com/en/sales
• https://www.mckinsey.com/capabilities/growth-marketing-and-sales/our-insights
• https://bridgegroupinc.com/resources
• https://www.forbes.com/sales

Related on PULSE

• When should a Series A company hire its first full-time VP of Sales?
• How do you build a pipeline coverage ratio that actually predicts quota attainment?
• What does a 90-day sales turnaround plan look like at an early-stage company?
• How do you tell the difference between a sales execution problem and a product-market fit problem?
• What should a board expect from a fractional revenue leader before a Series B raise?